Ironwood Pharmaceuticals | IRWD - Umsatzkosten





Umsatzkosten Veränderung Datum
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Akebia Therapeutics USD 10.34M 441K 2025-12
Almirall EUR 199.26M 7.76M 2026-06
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
Amarin USD 26.05M 1.41M 2025-12
Ardelyx USD 4.81M 6.04M 2026-03
Astellas Pharma JPY 129.43B 19.7B 2026-03
AstraZeneca USD 2.52B 2.73B 2026-06
Charles River Laboratories USD 716.51M 5.76M 2026-03
Coherus Biosciences USD 4.04M 324K 2025-12
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
Incyte USD 104.96M 457K 2026-06
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
MacroGenics USD 9.53M 585K 2026-03
Moderna USD 93M 862M 2026-06
Myriad Genetics USD 63M 1.1M 2025-12
Pacira USD 50.74M 3.89M 2026-03
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
Takeda JPY 517.6B 42.94B 2026-06
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12